In diabetes management, peptide-based therapies may reduce long-term complications and associated healthcare costs despite higher initial drug expenses
Medical Perspective If you are taking Wegovy and experience headaches with vision changes, severe nausea, confusion, difficulty speaking, weakness, or sudden intense pain, its important to seek emergency care immediately
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial, PubMed
Consult healthcare provider for individual assessment of medication interactions